SUSQUEHANNA INTERNATIONAL GROUP, LLP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,087,079
-48.3%
67,125
-35.4%
0.00%
Q2 2023$5,973,260
+49.3%
103,937
-2.6%
0.00%
Q1 2023$4,000,388
+213.1%
106,677
+133.9%
0.00%
Q4 2022$1,277,712
-48.3%
45,600
-48.2%
0.00%
Q3 2022$2,473,000
-59.5%
87,968
-49.8%
0.00%
-100.0%
Q2 2022$6,101,000
+99.1%
175,381
+105.4%
0.00%
Q1 2022$3,065,000
+543.9%
85,382
+228.7%
0.00%
Q1 2021$476,000
+18.4%
25,974
+29.6%
0.00%
Q4 2020$402,000
-79.4%
20,034
-80.7%
0.00%
Q3 2020$1,948,000
-22.0%
103,877
-6.5%
0.00%
Q2 2020$2,496,000
+434.5%
111,134
+253.3%
0.00%
Q1 2020$467,000
-26.9%
31,458
-5.1%
0.00%
Q4 2019$639,000
-40.1%
33,133
-38.3%
0.00%
Q3 2019$1,066,000
-75.8%
53,741
-74.2%
0.00%
Q2 2019$4,403,000
+1161.6%
208,562
+810.9%
0.00%
Q2 2018$349,000
-50.3%
22,895
-52.7%
0.00%
Q1 2017$702,000
-59.4%
48,400
-48.4%
0.00%
-100.0%
Q4 2016$1,728,000
+148.3%
93,823
+155.6%
0.00%
Q3 2016$696,000
+6.9%
36,700
-9.2%
0.00%
Q2 2016$651,000
-8.8%
40,400
-19.5%
0.00%
Q4 2015$714,000
+66.0%
50,177
+36.7%
0.00%
Q3 2015$430,000
-53.2%
36,713
-29.8%
0.00%
Q2 2015$919,00052,2870.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders